Acute kidney injury - Nursing Case Study
Pathophysiology
• Primary mechanism: Reduced renal perfusion leads to prerenal acute kidney injury (AKI). This occurs when there is decreased blood flow to the kidneys, often due to conditions like dehydration, heart failure, or blood loss, impairing the kidneys' ability to filter waste effectively.
• Secondary mechanism: Direct damage to kidney tissues, known as intrinsic AKI. Causes include ischemia from prolonged hypoperfusion, nephrotoxic drugs, or acute glomerulonephritis, which can lead to inflammation and cellular injury, disrupting normal kidney function.
• Key complication: If untreated, AKI can progress to chronic kidney disease or result in electrolyte imbalances, fluid overload, and accumulation of metabolic waste, significantly impacting overall health and potentially leading to life-threatening conditions.
Patient Profile
Demographics:
58-year-old male, construction worker
History:
• Key past medical history: Hypertension, Type 2 Diabetes, Hyperlipidemia
• Current medications: Lisinopril, Metformin, Atorvastatin
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Decreased urine output and swelling in legs
• Key symptoms: Nausea, fatigue, confusion, lower extremity edema
• Vital signs: Blood pressure 150/95 mmHg, heart rate 105 bpm, respiratory rate 22 breaths/min, temperature 99.1°F, oxygen saturation 94% on room air
Section 1
As the clinical team continues to assess the patient, initial laboratory results reveal significant abnormalities. The patient's serum creatinine level has risen to 3.5 mg/dL from a baseline of 1.1 mg/dL, indicating a marked decline in kidney function. Blood urea nitrogen (BUN) is elevated at 55 mg/dL, suggesting impaired renal clearance. Electrolyte imbalances are noted, with a potassium level of 5.8 mEq/L, raising concerns for potential cardiac arrhythmias. Urinalysis shows significant proteinuria and the presence of granular casts, indicative of intrinsic renal damage, possibly from nephron injury due to prolonged ischemia.
The patient's condition evolves as he develops worsening peripheral edema, and his weight has increased by 8 pounds over the past two days, pointing towards fluid retention. Despite initial fluid resuscitation, his urine output remains low at 250 mL over the last 24 hours, further confirming oliguria. The patient's mental status is deteriorating with increased confusion, raising the suspicion of uremic encephalopathy secondary to toxin accumulation. His respiratory rate has increased to 28 breaths per minute, and he reports new onset shortness of breath, suggesting possible fluid overload impacting respiratory function.
In response to these developments, the clinical team considers initiating renal replacement therapy to address the critical electrolyte imbalances and fluid overload. The patient's blood pressure remains elevated at 160/100 mmHg, necessitating careful management to improve renal perfusion without exacerbating the fluid overload. The team plans to adjust the patient's medication regimen, potentially transitioning from Lisinopril to another antihypertensive less reliant on renal elimination. These steps highlight the need for nuanced clinical reasoning, balancing interventions to stabilize the patient while preparing for potential dialysis, thereby preventing further deterioration.
Section 2
As the clinical team proceeds with the management plan, a new set of diagnostic results returns, providing further insight into the patient's condition. A chest X-ray reveals bilateral pleural effusions, corroborating the suspicion of fluid overload impacting respiratory function. Echocardiography is performed and shows reduced left ventricular ejection fraction at 40%, suggesting a possible element of heart failure contributing to the patient's fluid retention and pulmonary symptoms. These findings necessitate a careful reassessment of the fluid management strategy and highlight the need to delineate between cardiogenic and renal causes of the patient's acute deterioration.
Simultaneously, a repeat set of laboratory tests reveals a further increase in serum potassium to 6.2 mEq/L, intensifying the risk for cardiac arrhythmias. The patient's serum bicarbonate level is noted to be low at 18 mEq/L, indicating metabolic acidosis. This acid-base disturbance, coupled with the ongoing rise in uremic toxins, supports the urgent consideration of renal replacement therapy. The nephrology team is consulted, and preparations are made for hemodialysis initiation, as conservative measures alone are deemed insufficient in rapidly correcting the severe electrolyte imbalances and acidosis.
In light of these developments, the clinical team adjusts the patient's medication regimen. Lisinopril is discontinued, and a calcium channel blocker is initiated to manage the patient's hypertension while minimizing further renal compromise. Additionally, a diuretic is cautiously introduced to address the fluid overload, pending dialysis commencement. The team remains vigilant, monitoring the patient for any signs of cardiac instability or further respiratory compromise, and prepares to escalate care should the patient's condition demand it. These steps underscore the complexity of managing acute kidney injury with evolving complications, emphasizing the importance of timely interventions and multidisciplinary collaboration.
Section 3
As the clinical team closely monitors the patient following the initiation of hemodialysis, they observe a gradual improvement in both respiratory function and electrolyte balance. The patient's serum potassium level decreases to 5.0 mEq/L, reducing the immediate risk of cardiac arrhythmias. Metabolic acidosis shows signs of correction, with serum bicarbonate levels rising to 21 mEq/L. The patient reports feeling less breathless, and auscultation reveals diminished crackles in the lung bases, indicating partial resolution of the pulmonary edema.
However, during a routine examination, the nurse notes new-onset tachycardia with a heart rate of 110 beats per minute and a drop in blood pressure to 100/60 mmHg. The patient also complains of mild chest discomfort and appears slightly diaphoretic. An urgent electrocardiogram (ECG) is performed, revealing non-specific ST segment changes, which prompts further investigation to rule out ischemic changes or electrolyte-related disturbances.
This change in the patient's cardiovascular status necessitates a re-evaluation of the current treatment approach. The team considers the possibility of dialysis-induced hemodynamic instability and the potential need for volume adjustment, either through modifying the diuretic regimen or altering dialysis parameters to optimize fluid removal without compromising hemodynamic stability. Continuous cardiac monitoring is initiated, and the medical team remains alert to any further signs of deterioration, ready to implement advanced cardiac support if necessary. This development underscores the delicate balance required in managing complex cases of acute kidney injury with concurrent cardiac involvement, highlighting the critical role of ongoing assessment and dynamic treatment adjustments.
Section 4
As the medical team continues to monitor the patient's condition, they decide to perform a series of diagnostic tests to gain a clearer understanding of the underlying issues contributing to the new cardiovascular symptoms. Blood tests reveal a slight decline in hemoglobin levels to 9.8 g/dL, suggesting the possibility of mild anemia, which could be contributing to the patient's tachycardia and hypotension. Additionally, serum calcium levels are found to be low at 8.0 mg/dL, raising concerns about potential hypocalcemia, a condition that can affect cardiac function and stability. To address these findings, the team considers the need for calcium supplementation and a possible transfusion if anemia worsens.
The echocardiogram performed alongside the ECG shows a mild decrease in left ventricular ejection fraction, now at 45%, indicating some degree of cardiac dysfunction that may be exacerbating the patient's hemodynamic instability. This finding prompts the team to review the patient's medication regimen, particularly the use of beta-blockers or other agents that could be adjusted to support cardiac output without further lowering blood pressure. The interdisciplinary team discusses the potential benefits of introducing a low-dose inotropic agent to enhance myocardial contractility while continuing with cautious fluid management to prevent further overloading the cardiovascular system.
Despite these challenges, the patient remains responsive and communicative, allowing the nursing staff to engage in ongoing education about recognizing symptoms of worsening cardiac function and the importance of adherence to the treatment plan. The team emphasizes the need for vigilance in monitoring for signs of decreased perfusion, such as altered mental status or reduced urine output, which could indicate further complications requiring immediate intervention. This careful balance of treatment adjustments and monitoring is crucial as the team works to stabilize the patient's condition and prevent further deterioration.
Section 5
As the medical team closely monitors the patient, there is a notable change in the patient's status. Overnight, the patient experiences a sudden onset of confusion and restlessness, and the nursing staff reports a decrease in urine output to less than 20 mL/hour, raising concerns about further deterioration in renal function and perfusion. Vital signs indicate a heart rate of 115 beats per minute, blood pressure of 88/54 mmHg, and respiratory rate of 24 breaths per minute. These changes suggest worsening hemodynamic instability, prompting immediate reevaluation of the treatment plan.
A repeat set of laboratory tests reveals a further decline in renal function, with serum creatinine rising to 3.2 mg/dL from 2.5 mg/dL and blood urea nitrogen (BUN) increasing to 48 mg/dL. Additionally, the patient's potassium level is elevated at 5.8 mEq/L, indicating hyperkalemia, which poses a significant risk for cardiac arrhythmias. The interdisciplinary team determines that immediate intervention is required to address these complications. The decision is made to initiate renal replacement therapy to support the kidneys and manage electrolyte imbalances, alongside cautious administration of calcium gluconate to stabilize cardiac membranes and prevent arrhythmias associated with hyperkalemia.
With these developments, the nursing team intensifies monitoring efforts and reinforces education with the patient and family about recognizing early signs of complications. They focus on the importance of reporting any new or worsening symptoms, such as increased confusion or further reduction in urine output. The team prepares for potential adjustments in the treatment plan, including the introduction of more aggressive inotropic support if the patient's cardiac function continues to decline. This proactive approach aims to stabilize the patient's condition while minimizing the risk of further complications, providing a critical window for recovery as the patient's journey continues.